Herbal Monograph
Rosemary
Salvia rosmarinus Spenn.
Lamiaceae (Labiatae)
Premier circulatory stimulant and cognitive tonic with Commission E approval for dyspepsia, rheumatic complaints...
Overview
Plant Description
Rosemary is an evergreen, densely branched, aromatic shrub typically growing 0.5-2 meters (1.5-6.5 feet) tall, though occasionally reaching 2.5 meters under favorable conditions. The stems are woody at the base, becoming herbaceous toward the growing tips, square in cross-section (characteristic of the Lamiaceae family), and covered with a greyish-brown bark on older wood. Young stems are green and finely pubescent. The leaves are sessile (stalkless), opposite, linear to lanceolate, 2-4 cm long and 2-4 mm wide, with strongly revolute (rolled-under) margins that give them a distinctive needle-like appearance. The upper leaf surface is dark green, coriaceous (leathery), and finely rugose (wrinkled), while the lower surface is densely covered with white to grey stellate tomentum (star-shaped hairs), giving it a silvery-white appearance. The leaves are highly aromatic when crushed, releasing a characteristic camphoraceous, pine-like fragrance. Flowers are borne in short axillary racemes, typically appearing from late winter through spring (and sporadically year-round in mild climates). The calyx is bilabiate, campanulate, and pubescent. The corolla is bilabiate (two-lipped), 10-15 mm long, typically pale blue to violet-blue, though white and pink-flowered cultivars exist. The upper lip is erect and bilobed; the lower lip is three-lobed with the central lobe largest, concave, and often marked with darker spots. Two stamens with curved filaments protrude beyond the corolla. The fruit consists of four smooth, ovoid nutlets (schizocarps), dark brown when mature.
Habitat
Native to the Mediterranean Basin, where it grows wild on dry, rocky, calcareous (limestone) hillsides, coastal cliffs, maquis (scrubland), and garrigue vegetation from sea level to approximately 1,500 meters elevation. Thrives in full sun on well-drained, sandy or rocky soils of low to moderate fertility. Tolerates poor, alkaline soils and drought conditions once established but is sensitive to waterlogging and prolonged freezing temperatures. The natural range extends from Portugal and Spain eastward through southern France, Italy, the Adriatic coast, Greece, Turkey, and into the Levant and North Africa (Morocco, Tunisia, Libya).
Distribution
Native throughout the Mediterranean Basin from the Iberian Peninsula through southern Europe, North Africa, and the Near East. Now widely cultivated as a culinary, ornamental, and medicinal herb in temperate, subtropical, and Mediterranean climate zones worldwide, including California and the southwestern United States, Australia, South Africa, and South America. Naturalized in many regions beyond its native range, including parts of coastal California, southeastern Australia, and the Canary Islands. Commercial cultivation for essential oil production is concentrated in Spain, Tunisia, Morocco, France, Italy, Turkey, and increasingly in China and India.
Parts Used
Leaf (Rosmarini folium)
Preferred: Dried whole or cut leaf for infusion or decoction; tincture (1:5 in 45% ethanol); fluid extract; encapsulated powdered leaf or standardized extract
The dried leaf is the official drug in the European Pharmacopoeia (Ph.Eur., Rosmarini folium), British Herbal Pharmacopoeia, and the Commission E monograph. It is the primary medicinal part used in both internal and external preparations. The leaf contains the essential oil (minimum 1.2% v/w per Ph.Eur.), phenolic diterpenes (carnosic acid, carnosol), rosmarinic acid, and flavonoids. Used dried for infusions, tinctures, and encapsulated products. The pharmacopeial drug consists of the whole or cut dried leaves, which are linear, 1.5-4 cm long, dark green on the upper surface, and white-tomentose on the lower surface.
Essential oil (Rosmarini aetheroleum)
Preferred: External: diluted in carrier oil (2-5% concentration) for massage, in bath preparations (6-10 drops per bath), in liniments and topical formulations. Internal: only under professional guidance, in enteric-coated capsules.
The essential oil obtained by steam distillation of the fresh or dried flowering aerial parts is a separate pharmacopeial drug (Ph.Eur., Rosmarini aetheroleum). It is a clear, colorless to pale yellow liquid with a characteristic camphoraceous, fresh, herbal odor. The oil composition varies significantly by chemotype: ct. 1,8-cineole (dominant in North African and Spanish oils), ct. camphor (common in Spanish and French oils), and ct. verbenone (found in Corsican and some French oils). The essential oil is used externally in liniments, bath preparations, massage oils, and topical formulations for musculoskeletal complaints and circulatory support. Internal use of the essential oil requires professional guidance and is generally not recommended for self-medication. The EMA specifies rosemary oil for cutaneous use and bath additives.
Rosemary oleoresin and supercritical CO2 extract
Preferred: Standardized extract capsules (typically standardized to carnosic acid content); food-grade antioxidant preparations
Commercially produced oleoresin obtained by solvent extraction or supercritical carbon dioxide extraction. Concentrated source of lipophilic antioxidant compounds, particularly carnosic acid and carnosol. Widely used in the food industry as a natural antioxidant preservative (E392 in the EU). Also employed in standardized herbal extract products for its high concentration of phenolic diterpenes. Supercritical CO2 extracts offer a solvent-free, concentrated preparation with preserved volatile and non-volatile constituents.
Key Constituents
Essential oil (volatile terpenes and terpenoids)
The essential oil is responsible for rosemary's aromatic, carminative, antimicrobial, and rubefacient properties. Chemotype variation is clinically significant: the 1,8-cineole chemotype is preferred for respiratory and cognitive indications; the camphor chemotype for external musculoskeletal use (rubefacient liniments) but carries higher neurotoxic risk; the verbenone chemotype is preferred for hepatobiliary support and is considered safest for limited internal use. The Commission E monograph approves rosemary leaf and oil for internal use (dyspepsia) and external use (circulatory support, rheumatic complaints). The essential oil contributes approximately 1.0-2.5% of the dried leaf by weight (European Pharmacopoeia minimum: 1.2% v/w). Inhalation of rosemary essential oil has been associated with improved cognitive performance and alertness in human studies (Moss & Oliver 2012; Moss et al. 2003).
Phenolic acids (hydroxycinnamic acid derivatives)
Rosmarinic acid is the principal water-soluble antioxidant and anti-inflammatory constituent of rosemary leaf. It is efficiently extracted by aqueous infusion (tea) and hydroalcoholic tincture. Its strong antioxidant capacity, anti-inflammatory effects (complement inhibition, LOX/COX inhibition), and anti-allergic properties (mast cell stabilization) contribute to rosemary's traditional indications for inflammatory conditions, digestive complaints, and respiratory catarrh. Rosmarinic acid's neuroprotective properties (amyloid-beta inhibition, antioxidant protection of neuronal cells) are of significant research interest for neurodegenerative disease prevention. The compound is a quality marker for rosemary leaf preparations in European pharmacopeias.
Phenolic diterpenes (abietane-type)
The phenolic diterpenes (carnosic acid and carnosol) are the primary lipophilic antioxidant constituents of rosemary and among the most potent naturally occurring antioxidants known. They are the basis for rosemary extract's EU-approved status as a food antioxidant (E392). Therapeutically, carnosic acid's activation of the Nrf2 cytoprotective pathway represents a novel mechanism for neuroprotection distinct from direct free-radical scavenging. This pathway-mediated neuroprotection provides a pharmacological basis for rosemary's traditional reputation as a memory herb and its modern research application in neurodegenerative disease prevention. Carnosol's multi-target anti-inflammatory and anticancer activity in preclinical models is an active area of research. These compounds are best extracted by alcoholic or lipophilic solvents; they are poorly extracted by aqueous infusion alone.
Flavonoids
The flavonoid fraction contributes to rosemary's antioxidant, anti-inflammatory, antispasmodic, and mild anxiolytic properties. While individually present in small concentrations, the combined flavonoid content works synergistically with rosmarinic acid and the phenolic diterpenes. Diosmin's venotonic activity may contribute to circulatory-supporting effects. Apigenin's GABAergic activity supports the herb's use as a mild nervine. The flavonoids are moderately water-soluble and are extracted in both infusions and tinctures.
Triterpenes and triterpene acids
The triterpene acids (ursolic and oleanolic acids) are quantitatively significant constituents of rosemary leaf and contribute substantially to its hepatoprotective and anti-inflammatory activity. Ursolic acid's multi-target pharmacology (anti-inflammatory, anti-tumor, metabolic-regulatory) aligns with rosemary's broad traditional therapeutic profile. These compounds are lipophilic and best extracted by alcoholic solvents or supercritical CO2 extraction. They are not efficiently extracted in aqueous infusions.
Herbal Actions
Rosemary is one of the pre-eminent circulatory stimulant herbs in the Western herbal tradition. It enhances peripheral blood flow through a combination of rubefacient essential oil components (camphor, 1,8-cineole) that cause local vasodilation when applied topically, and systemic circulatory stimulation through improved cardiac output and vascular tone. The Commission E monograph approves rosemary for 'supportive therapy for rheumatic diseases' and 'circulatory problems' (external use). David Hoffmann (Medical Herbalism, 2003) classifies rosemary as the primary circulatory stimulant herb, indicated when poor peripheral circulation contributes to cold extremities, cognitive sluggishness, headache, or impaired recovery. The herb is traditionally combined with Zingiber officinale (ginger) and Capsicum spp. (cayenne) to enhance circulatory delivery of other herbs in formulas.
[1, 2, 3, 5]Relieves intestinal gas and bloating
The volatile oil content, particularly 1,8-cineole, alpha-pinene, and borneol, provides carminative action by relaxing smooth muscle in the gastrointestinal tract, promoting the expulsion of intestinal gas, and reducing bloating and colic. The Commission E monograph specifically approves rosemary leaf for 'dyspeptic complaints' (internal use). The EMA community herbal monograph lists 'relief of flatulence and slight spasmodic disorders of the gastrointestinal tract' as a traditional use. The carminative action is complemented by the herb's ability to stimulate digestive secretions (bitter-aromatic action), improving overall digestive efficiency.
[1, 2, 3, 4]Relieves smooth muscle spasm
Rosemary essential oil components and flavonoids (particularly cirsimaritin) relax smooth muscle in the gastrointestinal tract, biliary system, and uterus. In vitro studies demonstrate dose-dependent relaxation of intestinal and tracheal smooth muscle preparations. The antispasmodic action supports the traditional use for colic, intestinal cramping, and dysmenorrhea. The choleretic effect (stimulation of bile flow) combined with biliary antispasmodic activity is particularly relevant to the Commission E indication for dyspepsia.
[1, 3, 4]Multiple human studies support rosemary's cognitive-enhancing effects. Moss and Oliver (2012) demonstrated that inhalation of rosemary essential oil aroma significantly improved performance on cognitive tasks (speed and accuracy) and was associated with elevated plasma 1,8-cineole levels, suggesting absorption of a pharmacologically active terpene through the nasal mucosa. Pengelly et al. (2012) demonstrated in a randomized, placebo-controlled trial that oral administration of dried rosemary leaf powder (750 mg, the lowest dose tested) significantly improved speed of memory in older adults. Perry et al. (2003) and Kennedy et al. (2011) demonstrated that rosemary essential oil constituents inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), providing a pharmacological mechanism for cognitive enhancement analogous to cholinesterase inhibitor drugs used in Alzheimer disease. Carnosic acid activates the Nrf2 neuroprotective pathway (Satoh et al. 2008). The traditional reputation of rosemary as 'the herb of remembrance' is thus supported by modern pharmacological and clinical evidence.
[3, 7, 8, 10, 11]Prevents or slows oxidative damage to cells
Rosemary is one of the most potent antioxidant herbs known, containing multiple classes of antioxidant compounds acting through diverse mechanisms. Carnosic acid and carnosol are extraordinarily potent lipid-phase antioxidants (the basis for EU food-additive approval E392). Rosmarinic acid is a strong aqueous-phase antioxidant. The essential oil terpenes contribute additional radical-scavenging capacity. In vivo, rosemary extract has been shown to increase plasma antioxidant capacity, reduce oxidative stress biomarkers (MDA, 8-OHdG), and upregulate endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase) via Nrf2 activation. This multi-level antioxidant activity underpins many of rosemary's other therapeutic actions (neuroprotective, hepatoprotective, anti-inflammatory).
[2, 4, 11]Protects the liver from damage
Rosemary demonstrates hepatoprotective activity through multiple mechanisms: carnosic acid and carnosol protect hepatocytes from oxidative damage via Nrf2-mediated upregulation of antioxidant enzymes; ursolic and oleanolic acids reduce hepatic inflammation and fibrosis in animal models; the choleretic effect (stimulation of bile production and flow) supports healthy hepatobiliary function. Animal studies demonstrate protection against CCl4-induced, acetaminophen-induced, and alcohol-induced liver injury. Hoffmann (2003) recommends rosemary as a choleretic and hepatoprotective herb. The verbenone chemotype essential oil is particularly valued in French aromatic medicine for hepatocyte-regenerating properties.
[2, 3, 4]Kills or inhibits the growth of microorganisms
Rosemary essential oil and extracts demonstrate broad-spectrum antimicrobial activity against Gram-positive bacteria (Staphylococcus aureus, including MRSA; Bacillus subtilis; Listeria monocytogenes), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa), and fungi (Candida albicans, Aspergillus niger). The essential oil components (1,8-cineole, alpha-pinene, camphor) disrupt microbial cell membrane integrity. Rosmarinic acid and carnosic acid contribute additional antimicrobial effects. Clinical applications include topical wound care, oral rinses for periodontal health, and food preservation. The antimicrobial activity is primarily relevant to external/topical applications rather than systemic antimicrobial therapy.
[2, 4]Rosemary is classified as a stimulating nervine tonic in Western herbal medicine, distinct from the sedating nervines (valerian, passionflower). It gently stimulates and tonifies the nervous system, improving alertness, concentration, and mental clarity without the agitation associated with caffeine. Hoffmann (2003) classifies rosemary as a nervine tonic indicated for nervous debility, mental exhaustion, nervous headache, and depression associated with cerebral insufficiency. The combination of circulatory stimulation (improving cerebral blood flow) with direct cholinesterase inhibition and Nrf2-mediated neuroprotection provides a multi-mechanism basis for the nervine tonic action.
[3, 4, 5]Promotes perspiration
Rosemary has mild diaphoretic (sweat-promoting) properties when taken as a hot infusion, supporting its traditional use in feverish conditions and upper respiratory infections. The warming, stimulating nature of the herb promotes peripheral vasodilation and perspiration. This action is secondary and rosemary is not considered a primary diaphoretic; it is more commonly combined with elderflower (Sambucus nigra) and peppermint (Mentha piperita) in diaphoretic formulas.
[3, 5]Rosemary stimulates the production and flow of bile from the liver and gallbladder, supporting fat digestion and hepatobiliary function. The choleretic action is attributed to the combined effects of the essential oil (particularly borneol and verbenone), bitter principles, and phenolic diterpenes. This action underpins the Commission E approval for dyspeptic complaints and rosemary's traditional role in supporting sluggish digestion associated with inadequate bile secretion.
[1, 3, 4]Reduces inflammation
Multiple rosemary constituents demonstrate anti-inflammatory activity through distinct mechanisms: rosmarinic acid inhibits complement activation, lipoxygenase (5-LOX), and cyclooxygenase (COX-1, COX-2); carnosol and carnosic acid inhibit NF-kB and iNOS; ursolic acid inhibits COX-2, 5-LOX, and elastase; essential oil components (1,8-cineole) suppress pro-inflammatory cytokine production. The combined anti-inflammatory activity supports rosemary's traditional external use for rheumatic complaints and internal use for inflammatory gastrointestinal conditions.
[1, 2, 4]Therapeutic Indications
Nervous System
Cognitive enhancement and memory support
Rosemary has the strongest clinical evidence base of any traditional herb for cognitive enhancement. Moss and Oliver (2012) demonstrated in a controlled study that inhalation of rosemary essential oil aroma significantly improved cognitive performance (speed and accuracy on cognitive tasks) in healthy adults, with plasma 1,8-cineole levels correlating positively with performance. Pengelly et al. (2012) showed in a randomized, double-blind, placebo-controlled trial that oral rosemary powder (750 mg) significantly improved speed of memory in adults over 65 years. Kennedy et al. (2011) demonstrated dose-dependent cognitive effects of rosemary extract. Pharmacological mechanisms include: (1) cholinesterase inhibition by alpha-pinene, 1,8-cineole, and rosmarinic acid; (2) Nrf2-mediated neuroprotection by carnosic acid (Satoh et al. 2008); (3) improved cerebral blood flow via circulatory stimulation; (4) antioxidant protection of neuronal tissue. The traditional reputation of rosemary as 'the herb of remembrance' (dating to ancient Greece) is substantiated by this convergence of clinical and pharmacological evidence.
[3, 7, 8, 10, 11]Headache (nervous headache, headache with coldness)
The Commission E monograph lists rosemary among herbs indicated for headache support. The British Herbal Pharmacopoeia (1996) lists headache as an indication for rosemary. The mechanism involves improved cerebral circulation (circulatory stimulant action), anti-inflammatory effects, and antispasmodic relaxation of vascular smooth muscle. In Western herbal energetics, rosemary is specifically indicated for headaches associated with coldness, poor circulation, and mental dullness -- the 'cold, congestive' headache pattern. Applied topically as diluted essential oil to the temples, rosemary provides additional relief via local rubefacient and analgesic effects of camphor and 1,8-cineole.
[1, 3, 5]Mental fatigue, nervous exhaustion, and mild depressive states
Rosemary is traditionally indicated as a stimulating nervine tonic for nervous debility, mental exhaustion, mild depression (particularly the cold, apathetic type associated with cerebral insufficiency), and convalescent fatigue. Hoffmann (2003) specifically recommends rosemary for 'debility associated with circulatory weakness.' The BHP (1996) lists 'depressive states with general debility' as an indication. The mechanism combines circulatory stimulation to the brain, cholinesterase inhibition (enhancing cholinergic neurotransmission), and the uplifting effects of the aromatic volatile oil on mood and alertness.
[3, 4, 5]Digestive System
Dyspepsia (functional dyspepsia, indigestion)
The Commission E monograph gives rosemary a positive assessment for 'dyspeptic complaints' as an internal indication. The EMA community herbal monograph (2010) classifies rosemary leaf as a 'traditional herbal medicinal product used to relieve symptoms of dyspepsia such as heartburn and flatulence.' The mechanism involves carminative relaxation of intestinal smooth muscle, stimulation of digestive secretions (including gastric acid, pancreatic enzymes, and bile), and antispasmodic relief of intestinal cramping. The combination of bitter (choleretic) and aromatic (carminative) properties makes rosemary particularly effective for dyspepsia associated with sluggish digestion, bloating, and inadequate bile secretion.
[1, 2, 3, 4]Flatulence and intestinal bloating
The EMA community herbal monograph explicitly lists 'relief of flatulence and slight spasmodic disorders of the gastrointestinal tract' as an approved traditional use. The carminative essential oil components relax intestinal smooth muscle, reducing gas accumulation and facilitating its expulsion. The Commission E monograph supports this indication under the broader 'dyspeptic complaints' approval.
[1, 2, 3]Loss of appetite (anorexia)
The Commission E monograph includes 'loss of appetite' as an approved internal indication for rosemary. The EMA monograph similarly lists 'loss of appetite' as a traditional use. The aromatic and bitter qualities of rosemary stimulate the appetite by promoting salivary, gastric, and biliary secretion. Rosemary is traditionally taken as a pre-meal infusion or added to culinary preparations to stimulate appetite and prepare the digestive system.
[1, 2]Hepatobiliary dysfunction and sluggish bile flow
Rosemary's choleretic action (stimulation of bile production and flow) supports its use for functional hepatobiliary complaints. The combination of essential oil borneol, phenolic diterpenes (carnosic acid, carnosol), and triterpene acids (ursolic, oleanolic) provides hepatoprotective and choleretic effects. Animal studies demonstrate increased bile flow and protection against hepatotoxic insults. Hoffmann (2003) recommends rosemary as a gentle liver tonic and choleretic. The verbenone chemotype is particularly valued for hepatobiliary support in French aromatic medicine.
[2, 3, 4]Musculoskeletal System
Rheumatic complaints and muscle pain (external use)
The Commission E monograph gives rosemary a positive assessment for 'supportive therapy for rheumatic diseases' as an external indication, specifically for rosemary oil in bath preparations and topical applications. The EMA monograph approves rosemary essential oil for 'relief of minor muscular pain' as a cutaneous application. The rubefacient action of camphor and 1,8-cineole in the essential oil causes local vasodilation, warming, and counter-irritant analgesic effects when applied topically. This increases blood flow to painful muscles and joints, aiding in removal of inflammatory mediators and metabolic waste products. Rosemary oil in bath preparations provides combined hydrotherapeutic and pharmacological benefit.
[1, 2, 3, 5]Circulatory disorders and peripheral vascular insufficiency (external use)
The Commission E monograph approves rosemary for 'circulatory problems' as an external indication. Rosemary oil baths and topical applications stimulate peripheral circulation through rubefacient vasodilation. This is particularly indicated for cold extremities, Raynaud-like symptoms, and general peripheral vascular insufficiency. The EMA monograph supports use for 'improvement of minor peripheral circulatory disorders' as a traditional indication.
[1, 2, 3]Cardiovascular System
Hypotension (low blood pressure support)
Rosemary is traditionally indicated for functional hypotension (low blood pressure with dizziness, fainting tendency, cold extremities, and fatigue). As a warming circulatory stimulant, rosemary increases peripheral vascular tone and mildly supports blood pressure. The Commission E lists 'circulatory problems' among rosemary's indications. Hoffmann (2003) specifically recommends rosemary for 'hypotension with associated dizziness and faintness.' The BHP (1996) lists 'cardiovascular debility' as an indication. This is the opposite indication from many cardiovascular herbs that lower blood pressure, and rosemary should be used with caution in hypertensive patients.
[1, 3, 5]Peripheral circulation support (cold extremities, poor capillary perfusion)
Rosemary enhances peripheral blood flow through circulatory stimulation (both systemic and local rubefacient effects). Traditionally combined with ginger and hawthorn for peripheral circulatory support. Indicated for cold hands and feet, chilblains, and conditions associated with inadequate peripheral perfusion.
[3, 4, 5]dermatological
Hair growth support and hair loss (topical use)
Panahi et al. (2015) conducted a randomized comparative trial of rosemary oil versus minoxidil 2% in patients with androgenetic alopecia over 6 months. Both groups showed significant increases in hair count from baseline, with no significant difference between rosemary oil and minoxidil at 6 months. The rosemary group had significantly less scalp itching as a side effect. The mechanism involves improved scalp circulation (rubefacient effect), anti-inflammatory activity, and possible anti-androgenic effects of ursolic acid. Rosemary hair rinse and scalp treatments are well-established in traditional European herbal practice for hair loss, dandruff, and premature greying.
[3, 9]Wound healing and skin care (topical use)
Rosemary's antimicrobial, anti-inflammatory, and antioxidant properties support its traditional topical use for minor wound care, skin irritation, and as a general skin tonic. The essential oil (diluted in carrier oil) is applied topically for its antimicrobial and vulnerary (wound-healing) properties. Rosemary hydrosol (floral water from distillation) is used as a gentle toner for oily and acne-prone skin.
[2, 3]Respiratory System
Upper respiratory catarrh, sinusitis, and nasal congestion
The essential oil, particularly 1,8-cineole, provides mucolytic, expectorant, and decongestant effects. Steam inhalation of rosemary essential oil (2-3 drops in a bowl of hot water) is a traditional remedy for nasal congestion, sinusitis, and upper respiratory catarrh. 1,8-Cineole has been demonstrated in clinical studies (though primarily with isolated eucalyptol/cineole preparations) to reduce mucus viscosity, enhance mucociliary clearance, and exert anti-inflammatory effects on respiratory mucosa. Rosemary's warming, drying energetic profile is well-suited to damp, congestive respiratory conditions.
[3, 4, 5]Energetics
Temperature
warm
Moisture
dry
Taste
Tissue States
cold/depression, damp/stagnation, damp/relaxation
In traditional Western herbal energetics, rosemary is classified as warming and drying -- a stimulating aromatic herb that moves stagnation, improves circulation, and enlivens cold, sluggish tissue states. The pungent, aromatic taste reflects its volatile oil content and stimulating nature; the slight bitterness reflects the diterpene and triterpene content and supports hepatobiliary function. Rosemary is specifically indicated for cold/depressed tissue states characterized by poor circulation, cold extremities, mental dullness, sluggish digestion, and pale, boggy tissue. It addresses damp/stagnant conditions including hepatic congestion, sluggish lymphatic drainage, and fluid retention. Its warming, drying nature makes it less suitable for individuals with pronounced heat or dryness (hot, dry constitutions with deficient yin), where cooling, moistening herbs would be preferred. In Ayurvedic terms, rosemary would be classified as reducing Kapha and Vata while potentially aggravating Pitta in excess. Matthew Wood (The Earthwise Herbal, 2008) emphasizes rosemary's affinity for the head and brain, calling it 'the herb that brings blood to the head,' and its specific indication for headache with coldness, poor memory, and cerebral insufficiency with depression. CAVEAT: Herbal energetics are interpretive frameworks within Western herbalism, not standardized across all practitioners.
Traditional Uses
Ancient Greek and Roman medicine
- Burned as incense in temples and sickrooms to purify the air and ward off disease (fumigatory)
- Worn in garlands by Greek students during examinations to improve memory and concentration
- Dioscorides (De Materia Medica, ca. 65 CE) recommended rosemary for jaundice (liver support) and as a warming herb
- Pliny the Elder recorded rosemary as beneficial for the eyes and liver
- Used in bath preparations for muscular aches and to invigorate the body
- Sacred to Aphrodite (Venus) and associated with love, fidelity, and remembrance
"In ancient Greece, rosemary was closely associated with memory and the intellect. Greek students wove rosemary garlands into their hair while studying for examinations, believing it strengthened memory. Dioscorides (ca. 65 CE) wrote of 'libanotis' (rosemary) in De Materia Medica, describing it as a warming herb useful for liver complaints and jaundice. The Romans burned rosemary as incense, used it in baths, and planted it extensively in gardens. Pliny the Elder (Naturalis Historia, 77 CE) discussed rosemary's value for the eyes and as a liver remedy. The association with remembrance persists in Western culture, notably in Shakespeare's Hamlet: 'There's rosemary, that's for remembrance.'"
Medieval and Renaissance European herbalism
- Central to the famous 'Hungary Water' (ca. 1370), one of the first alcohol-based herbal preparations in Europe, used as a rejuvenating tonic and cosmetic
- John Gerard (The Herball, 1597) recommended rosemary for 'weakness of the brain, cold diseases of the head,' strengthening memory, and restoring speech after stroke
- Nicholas Culpeper (The English Physician, 1652) classified rosemary as hot and dry in the second degree, under the dominion of the Sun, and recommended it for 'all cold diseases of the head and brain'
- Burned during plague epidemics as a disinfectant fumigant in hospitals and public spaces
- Used in bridal wreaths symbolizing fidelity and remembrance; placed in coffins for remembrance of the dead
- Applied externally as 'rosemary wine' for gout, rheumatic pain, and paralysis
"The history of rosemary in European herbal medicine is exceptionally well documented. Hungary Water (Aqua Reginae Hungariae), dating to approximately 1370, is one of the earliest European alcohol-based herbal preparations, consisting primarily of rosemary distilled in brandy. It was purportedly created for Queen Elizabeth of Hungary, who used it to rejuvenate her aging body. Gerard (1597) wrote: 'Rosemary comforteth the cold, weak, and feeble brain in a most wonderful manner.' Culpeper (1652) stated: 'It helps a weak memory and quickens the senses. It is very much used both for inward and outward diseases, for the virtues of it are not fully known to any.' During plague epidemics, rosemary was burned as a fumigant in hospitals and carried in nosegays (tussie-mussies) to protect against contagion."
Mediterranean folk medicine
- Infusion of leaves taken after meals as a digestive tonic throughout the Mediterranean region
- Rosemary wine (leaves macerated in red or white wine) used as a circulatory and liver tonic in Spanish, Italian, and French folk medicine
- Topical poultice or liniment of rosemary leaves applied to rheumatic joints and sore muscles
- Hair rinse of rosemary decoction used to prevent hair loss, reduce dandruff, and darken greying hair
- Steam inhalation of rosemary for colds, sinusitis, and headache
- Rosemary honey (miel de romero) from Spain and southern France valued for respiratory and digestive complaints
"Throughout the Mediterranean basin, rosemary has been used continuously in folk medicine for millennia. In Spain, 'romero' is among the most widely used medicinal plants, taken as an infusion for digestive complaints, headache, and poor circulation. Italian folk medicine employs 'rosmarino' as a digestive aid, hair tonic, and topical analgesic. In Provence and Corsica, rosemary features prominently in traditional remedies and is the source of highly prized essential oils of distinct chemotypes. The herb is so deeply embedded in Mediterranean culture that many uses blur the line between culinary, medicinal, and ceremonial applications."
Traditional European phytotherapy (modern Western herbalism)
- Internal: infusion or tincture for poor circulation, cold extremities, hypotension, and cardiovascular debility
- Internal: carminative and choleretic for dyspepsia, flatulence, hepatobiliary insufficiency, and loss of appetite
- Internal: nervine tonic for mental fatigue, poor concentration, nervous headache, and mild depression
- External: essential oil in bath preparations for muscular pain, rheumatic complaints, and poor circulation (Commission E)
- External: diluted essential oil for scalp massage to promote hair growth and reduce hair loss
- Combined with other herbs: frequently combined with ginkgo (cerebral circulation), hawthorn (cardiovascular), milk thistle (hepatoprotection), or peppermint (digestion)
"In modern Western herbal practice, rosemary occupies a unique niche as a stimulating cerebrovascular and digestive tonic. Hoffmann (Medical Herbalism, 2003) describes it as 'a well-known and much-used tonic and stimulant with a wide range of applications.' Mills and Bone (Principles and Practice of Phytotherapy, 2013) classify rosemary as an aromatic bitter with circulatory stimulant, antioxidant, and neuroprotective properties, emphasizing the convergence of traditional use and modern pharmacological validation."
Modern Research
Rosemary aroma inhalation and cognitive performance
Controlled study investigating the effects of rosemary essential oil aroma exposure on cognitive performance and mood in healthy adults, with measurement of plasma 1,8-cineole levels to confirm systemic absorption.
Findings: Participants exposed to rosemary essential oil aroma (diffused in the testing room) showed significantly improved performance on cognitive tasks measuring speed and accuracy compared to controls in an unscented room. Plasma 1,8-cineole concentrations were significantly elevated in the rosemary aroma group, confirming systemic absorption of essential oil constituents through inhalation. Importantly, plasma 1,8-cineole levels positively correlated with improved cognitive performance, suggesting a pharmacological (not merely psychological) mechanism. The rosemary group also reported increased contentment and alertness on mood scales.
Limitations: Single-session design; long-term cognitive effects not assessed. Relatively small sample size. Cognitive tasks were laboratory-based and may not fully reflect real-world cognitive demands. Cannot distinguish between pharmacological effects of absorbed terpenes and aromatic/olfactory influences on attention and mood. 1,8-Cineole levels varied between participants, suggesting individual differences in absorption.
[7]
Oral rosemary and speed of memory in older adults
Randomized, double-blind, placebo-controlled, dose-finding crossover study evaluating the effects of dried rosemary leaf powder on cognitive function in adults aged 65 and over.
Findings: The lowest dose tested (750 mg dried rosemary powder) produced a statistically significant improvement in speed of memory compared to placebo. Interestingly, the highest dose (6000 mg) impaired speed of memory, suggesting a biphasic dose-response curve. No significant effects on accuracy of memory at any dose. The 750 mg dose is comparable to the amount of rosemary typically used in culinary quantities (a normal seasoning portion), suggesting that dietary rosemary consumption may confer cognitive benefits in older adults.
Limitations: Crossover design with washout periods. Acute (single-dose) effects measured; chronic supplementation not evaluated. Small sample size (n=28). Elderly participants only; results may differ in younger populations. Specific chemical composition of the rosemary powder not fully characterized (no chemotype or standardization data reported).
[8]
Cholinesterase inhibition by rosemary essential oil and constituents
In vitro study evaluating the acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activity of rosemary essential oil and its individual terpenoid constituents, with relevance to Alzheimer disease and cognitive enhancement.
Findings: Rosemary essential oil demonstrated significant inhibition of both AChE and BuChE in vitro. Among individual constituents, 1,8-cineole and alpha-pinene were identified as the most active cholinesterase inhibitors. The IC50 values, while higher than pharmaceutical cholinesterase inhibitors (donepezil, galantamine), were considered pharmacologically relevant given the concentrations achievable through inhalation and oral consumption. The cholinesterase inhibition provides a pharmacological mechanism consistent with the observed cognitive-enhancing effects in human studies.
Limitations: In vitro study; enzyme inhibition in a test tube does not directly translate to in vivo cognitive effects. IC50 values are higher than pharmaceutical cholinesterase inhibitors. Brain tissue penetration and bioavailability of inhaled or ingested terpenes require further characterization. Synergistic or antagonistic interactions between multiple terpene components not fully evaluated.
[10]
Carnosic acid neuroprotection via Nrf2 pathway activation
Landmark mechanistic study demonstrating that carnosic acid from rosemary protects neurons from oxidative stress by activating the Keap1/Nrf2 transcriptional pathway, a novel mechanism distinct from direct antioxidant scavenging.
Findings: Carnosic acid activated the Keap1/Nrf2/ARE antioxidant response pathway in neuronal cells, upregulating expression of phase 2 antioxidant and detoxification enzymes including heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione S-transferase. This pathway-mediated protection was effective against oxidative stress-induced neuronal cell death (glutamate toxicity, hydrogen peroxide). Carnosic acid is an electrophilic compound that reacts with Keap1 cysteine residues, releasing Nrf2 to translocate to the nucleus and activate protective gene expression. This mechanism amplifies the cell's own antioxidant defenses rather than providing stoichiometric radical scavenging, making it potentially more effective at low concentrations.
Limitations: In vitro neuronal cell culture study. While the Nrf2 mechanism is well-validated, translation to in vivo neuroprotection in humans requires confirmation. Bioavailability of carnosic acid to brain tissue after oral ingestion needs further characterization. The study used purified carnosic acid, not whole rosemary extract.
[11]
Rosemary oil versus minoxidil for androgenetic alopecia
Randomized, single-blind, comparative trial of topical rosemary essential oil versus minoxidil 2% solution for the treatment of androgenetic alopecia over 6 months.
Findings: Both rosemary oil and minoxidil 2% groups showed significant increases in hair count from baseline at 6 months (P < 0.05). There was no statistically significant difference in hair count between the rosemary oil and minoxidil groups at the 6-month endpoint, suggesting comparable efficacy. The rosemary group experienced significantly less scalp itching as a side effect compared to the minoxidil group. Both treatments required at least 3 months before visible improvement, consistent with hair growth cycle dynamics.
Limitations: Relatively small sample size (n=100, 50 per group). Single-blind (assessor-blinded) rather than double-blind. No placebo control group (active comparator only). Minoxidil 2% used (rather than the stronger 5% formulation). Six-month follow-up; longer-term outcomes unknown. The specific rosemary oil formulation and application protocol were standardized but may not reflect all commercial products.
[9]
Carnosol anticancer pharmacology (comprehensive review)
Review article comprehensively summarizing the anticancer properties and molecular mechanisms of carnosol, the oxidation product of carnosic acid found in rosemary.
Findings: Carnosol has demonstrated anticancer activity in multiple cancer cell lines and animal models, including breast, prostate, colon, skin, and leukemia. Molecular mechanisms include: induction of apoptosis (via caspase activation and Bcl-2 family modulation), inhibition of cell proliferation (G2/M cell cycle arrest), suppression of NF-kB activation (reducing inflammation-driven carcinogenesis), inhibition of COX-2 and iNOS, modulation of the Akt/mTOR signaling pathway, and suppression of androgen and estrogen receptor signaling. Carnosol also shows chemopreventive activity, protecting against chemical carcinogenesis in animal models. Importantly, carnosol demonstrates selective cytotoxicity toward cancer cells while showing relatively low toxicity to normal cells.
Limitations: Review of predominantly in vitro and animal studies. No completed human clinical trials of carnosol or carnosic acid for cancer treatment or prevention at time of publication. Bioavailability to target tissues in humans not well characterized. Doses used in preclinical studies may not be achievable through dietary rosemary consumption or standard supplement doses.
[12]
EMA assessment report on Rosmarinus officinalis L., folium and aetheroleum
European Medicines Agency Committee on Herbal Medicinal Products (HMPC) comprehensive assessment report evaluating the clinical and non-clinical evidence base for rosemary leaf and essential oil, establishing regulatory status for traditional herbal medicinal products in the EU.
Findings: The EMA assessment concluded that rosemary leaf preparations have 'well-established use' or 'traditional use' status for multiple indications. For internal use: relief of dyspeptic complaints (heartburn, flatulence), loss of appetite. For external use (essential oil): relief of minor muscular pain, improvement of minor peripheral circulatory disorders. For bath additive use: supportive treatment of minor muscular and articular pain, improvement of peripheral circulation. The report reviewed the available clinical, pharmacological, and toxicological data and confirmed a favorable benefit-risk profile for the specified indications at recommended doses.
Limitations: Regulatory assessment rather than systematic review. Some indications classified under 'traditional use' status, meaning they are based on long-standing use rather than full clinical trial evidence. The assessment reflects available evidence as of the publication date and may not include the most recent clinical studies.
[2]
Rosemary extract antioxidant effects in human intervention studies
Systematic review and meta-analysis of human clinical studies evaluating the effects of rosemary or its extracts on oxidative stress biomarkers.
Findings: Rosemary supplementation in human studies has been associated with: reduced plasma malondialdehyde (MDA, a lipid peroxidation marker), increased plasma total antioxidant capacity (TAC), and modulation of inflammatory markers. The antioxidant effects are attributed to the combined action of rosmarinic acid (aqueous-phase antioxidant), carnosic acid/carnosol (lipid-phase antioxidants), and activation of the Nrf2 endogenous antioxidant pathway. The evidence supports rosemary as one of the most potent dietary antioxidant sources, consistent with its approved use as a food antioxidant (E392 in the EU).
Limitations: Heterogeneity across studies in terms of rosemary preparation, dose, duration, and study population. Many studies had small sample sizes. Long-term health outcomes (disease prevention) not demonstrated in clinical trials; oxidative stress markers are surrogate endpoints.
Preparations & Dosage
Infusion (Tea)
Strength: 2-4 g dried leaf per 150-250 mL boiling water. The infusion efficiently extracts rosmarinic acid and flavonoids (water-soluble antioxidants) but is less effective at extracting lipophilic diterpenes (carnosic acid) and triterpenes (ursolic acid).
Place 2-4 g (approximately 1-2 teaspoons) of dried rosemary leaf in a teapot or covered vessel. Pour 150-250 mL of freshly boiled water over the herb. Cover tightly (to prevent volatile oil loss through evaporation) and steep for 10-15 minutes. Strain and drink. For a stronger preparation, use up to 6 g of dried leaf per cup and steep for 15 minutes. The infusion should have a pleasant, aromatic, somewhat camphoraceous and pine-like character with mild bitterness.
2-4 g dried leaf per cup, 2-3 cups daily (Commission E: 4-6 g daily). EMA recommends 2 g per 150 mL, up to 3 times daily.
Two to three times daily, ideally 30 minutes before meals for digestive indications
May be used daily as a tonic infusion. Commission E and EMA do not specify duration limits. Traditionally used as a daily beverage herb in Mediterranean regions.
Not well-established for children under 12. Adolescents may use half adult dose under practitioner guidance. Small amounts as a culinary herb are safe for children.
Infusion is the simplest and most traditional internal preparation. Covering the vessel during steeping is essential to retain the volatile essential oil components, which would otherwise escape with the steam. The infusion is the preferred preparation for digestive indications (dyspepsia, flatulence, loss of appetite) as the aromatic oil directly contacts the gastrointestinal mucosa. For cognitive and circulatory indications, a tincture or standardized extract may provide a broader spectrum of active constituents (including lipophilic diterpenes). The infusion is also used externally as a hair rinse (cooled, applied after shampooing) for hair growth support and scalp health.
Tincture
Strength: 1:5, 45% ethanol (BHP specification). Some practitioners prefer 1:5, 60% ethanol for enhanced extraction of lipophilic constituents. Fresh plant tincture: 1:2, 65% ethanol.
Use dried rosemary leaf, finely cut. Standard maceration: 1:5 ratio in 45% ethanol (v/v). Place 200 g dried herb in a clean glass jar and add 1 L of 45% ethanol. Seal tightly and macerate for 2-4 weeks at room temperature, shaking daily. Press and filter through muslin or coffee filter. Store in amber glass bottles away from light and heat. A higher alcohol concentration (60%) may be used to improve extraction of lipophilic diterpenes (carnosic acid, ursolic acid).
2-4 mL (40-80 drops) three times daily. BHP dose: 1-4 mL of 1:5 tincture in 45% ethanol, three times daily.
Three times daily, taken in a small amount of water 15-30 minutes before meals for digestive indications
May be used long-term as a daily tonic. Reassess therapeutic need periodically.
Not recommended for children under 12 due to alcohol content and insufficient pediatric safety data.
The tincture provides a broader spectrum of active constituents than aqueous infusion, extracting both water-soluble phenolics (rosmarinic acid, flavonoids) and lipophilic compounds (carnosic acid, carnosol, ursolic acid, essential oil terpenes). This makes the tincture the preferred preparation for systemic indications (circulatory stimulation, cognitive enhancement, hepatoprotection, nervine tonic). The higher alcohol concentration (45-60%) compared to some herbal tinctures is advantageous for extracting the resinous phenolic diterpenes. Rosemary tincture is frequently combined with other herbs in formula: with Ginkgo biloba for cognitive support, with Crataegus spp. (hawthorn) for cardiovascular tonic, with Silybum marianum (milk thistle) for liver support, or with Zingiber officinale (ginger) for enhanced circulatory delivery.
essential-oil-bath
Strength: 6-10 drops essential oil per full bath (approximately 0.3-0.5 mL). Or 50 g dried herb per bath (Commission E).
Add 6-10 drops of rosemary essential oil to a full, warm bath (approximately 100 liters of water at 36-38 degrees C). For improved dispersion, pre-mix the essential oil with a small amount of bath milk, liquid soap, or full-fat milk before adding to the water. Soak for 15-20 minutes. Alternatively, dissolve 10 g dried rosemary leaf in 1 liter of hot water, steep 30 minutes, strain, and add the infusion to the bath water.
6-10 drops of essential oil per full bath, or 50 g dried rosemary leaf infused and added to bath water (Commission E). EMA: approximately 10 g essential oil per 100 L water.
Once daily or as needed for musculoskeletal pain and circulatory complaints
15-20 minutes per bath. May be used regularly as needed.
Not recommended for children under 6 years. Children 6-12 years: half adult dose under supervision.
Rosemary essential oil baths are specifically approved by the Commission E for 'supportive therapy for rheumatic diseases' and 'circulatory problems.' The combination of warm water immersion and volatile oil absorption through the skin and by inhalation provides both hydrotherapeutic and pharmacological benefits. The rubefacient terpenes (camphor, 1,8-cineole) cause peripheral vasodilation and warming, while the aromatic vapors provide respiratory and cognitive effects. Rosemary baths are traditionally taken in the morning rather than before bed, as the stimulating nature of the herb may interfere with sleep. Avoid in cases of large open wounds, fever, severe cardiac insufficiency, or hypertension (Commission E contraindications for rosemary baths).
liniment-and-massage-oil
Strength: Essential oil: 2-5% dilution in carrier oil. Liniment: approximately 1:10, herb to alcohol.
For massage oil: dilute rosemary essential oil at 2-5% concentration in a carrier oil (sweet almond, olive, or jojoba oil). For a 100 mL massage oil: add 2-5 mL (approximately 40-100 drops) of rosemary essential oil to 95-98 mL carrier oil. For a traditional liniment: macerate 100 g fresh or 50 g dried rosemary leaf in 500 mL rubbing alcohol (isopropanol) or vodka for 2-4 weeks. Strain and use topically.
Apply to affected areas 2-3 times daily. Massage gently into skin over affected muscles or joints. Do not apply to broken skin, mucous membranes, or near the eyes.
2-3 times daily as needed
Use as needed for symptomatic relief. No duration limits for topical use.
Not recommended for children under 6 years. Children 6-12 years: use at 1% dilution under adult supervision.
Topical rosemary preparations are the primary external application supported by the Commission E and EMA. The rubefacient action of camphor and 1,8-cineole produces local warming, vasodilation, and counter-irritant analgesia. Particularly indicated for chronic muscular tension, rheumatic and arthritic joint pain, lumbago, neuralgic pain, and poor peripheral circulation. The camphor chemotype essential oil is most commonly used for musculoskeletal applications due to its strong rubefacient character. Avoid contact with eyes, sensitive areas, and broken skin. Perform a patch test before first use to check for sensitivity.
Standardized Extract
Strength: Varies by product. Common DER 4:1 to 10:1 hydroalcoholic extract. Lipophilic extracts may be 20:1 or higher, concentrated in carnosic acid.
Commercially prepared standardized rosemary extracts are available in capsule and tablet form. Products may be standardized to rosmarinic acid content (common: >= 3-6%), carnosic acid content (common: >= 10-20% in lipophilic extracts), or total phenolic diterpenes. Choose products specifying the standardization marker and extraction method.
Rosmarinic acid-standardized extracts: 200-500 mg daily. Carnosic acid-standardized extracts: 150-400 mg daily. Follow specific product recommendations. Pengelly et al. (2012) used 750 mg whole dried rosemary powder for cognitive effects.
1-2 times daily, typically with meals
May be used long-term. Most clinical studies used acute (single-dose) or 4-12 week intervention periods.
Not established for standardized extracts in children.
Standardized extracts offer the most reproducible dosing for clinical applications, particularly for cognitive enhancement and antioxidant indications. The distinction between rosmarinic acid-standardized extracts (water-soluble antioxidant) and carnosic acid-standardized extracts (lipophilic antioxidant, Nrf2 activator) is clinically relevant. For neuroprotective applications, carnosic acid-standardized products may be preferred based on the Satoh et al. (2008) Nrf2 mechanism. For anti-inflammatory and anti-allergic applications, rosmarinic acid-rich extracts may be preferred. Product quality varies; choose manufacturers with third-party testing and clear standardization data.
hair-rinse
Strength: Infusion: 30-50 g dried leaf per liter of water. Oil: 5-10 drops essential oil per 30 mL carrier oil.
Prepare a strong infusion by steeping 30-50 g dried rosemary leaf in 1 liter of boiling water for 30 minutes. Strain thoroughly and allow to cool to a comfortable temperature. After shampooing and rinsing hair, pour the rosemary infusion slowly over the scalp and hair as a final rinse. Massage gently into the scalp for 1-2 minutes. Do not rinse out — leave in the hair to dry. Alternatively, add 5-10 drops of rosemary essential oil to 30 mL of carrier oil (jojoba or coconut) for a scalp massage treatment; apply to the scalp, leave for 30-60 minutes, then shampoo out.
Use the hair rinse 2-3 times per week. Scalp oil treatment: 1-2 times per week.
2-3 times weekly for hair rinse; 1-2 times weekly for oil treatment
Use consistently for a minimum of 3-6 months before evaluating efficacy, consistent with hair growth cycle timeframes (Panahi et al. 2015 measured outcomes at 6 months).
Not generally applicable. Safe for adolescents.
The Panahi et al. (2015) clinical trial demonstrating rosemary oil's comparable efficacy to minoxidil 2% for androgenetic alopecia provides clinical evidence supporting this traditional practice. The mechanism involves improved scalp circulation (rubefacient effect), anti-inflammatory activity reducing follicular inflammation, and potential anti-androgenic effects of ursolic acid. Traditional European practice has used rosemary hair rinses for centuries to promote hair growth, reduce dandruff, and maintain dark hair color. Results require consistent use over several months due to the slow pace of hair follicle cycling (anagen phase 2-6 years).
Safety & Interactions
Class 2b
Not to be used during lactation (AHPA Botanical Safety Handbook)
Contraindications
The AHPA Botanical Safety Handbook (2nd edition, 2013) classifies rosemary as class 2b — 'not to be used during pregnancy' in therapeutic doses. Rosemary has traditional use as an emmenagogue (menstruation-promoting agent), and the essential oil contains camphor which can stimulate uterine contractions at high doses. The Commission E monograph includes pregnancy as a contraindication for rosemary essential oil preparations. However, culinary use of rosemary (as a food seasoning) during pregnancy is considered safe by all authoritative sources. The concern applies specifically to concentrated preparations (tinctures, essential oils, standardized extracts) used at therapeutic doses, not to normal dietary consumption.
Individuals with confirmed allergy to rosemary or cross-reactive allergy to other Lamiaceae family members (sage, thyme, lavender, mint) should avoid rosemary preparations. Contact dermatitis from rosemary has been reported, though it is uncommon.
The Commission E monograph specifies these as contraindications for rosemary bath preparations. Rosemary baths can stimulate circulation and raise blood pressure mildly; in severe cardiac insufficiency or uncontrolled hypertension, this stimulation may be contraindicated. Open wounds and damaged skin allow excessive absorption of essential oil constituents, increasing the risk of irritation or systemic toxicity.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Anticoagulant and antiplatelet medications (warfarin, aspirin, clopidogrel) (Anticoagulants/Antiplatelets) | theoretical | Rosemary contains constituents that may theoretically affect hemostasis. Some in vitro data suggest mild antiplatelet effects. However, clinical evidence for a significant interaction is lacking. The AHPA and major drug interaction databases classify this as a theoretical rather than clinically documented interaction. |
| Lithium (Mood stabilizers) | theoretical | Rosemary has mild diuretic properties. Theoretically, any herb with diuretic effects could alter lithium excretion and affect serum lithium levels, potentially increasing the risk of lithium toxicity. |
| ACE inhibitors and antihypertensive medications (Antihypertensives) | theoretical | Rosemary is a traditional circulatory stimulant used for hypotension. In theory, its mild blood pressure-raising effect could partially counteract the effects of antihypertensive medications. Conversely, rosmarinic acid has demonstrated ACE inhibitory activity in vitro, which could theoretically potentiate ACE inhibitors. |
| Antidiabetic medications (metformin, sulfonylureas, insulin) (Hypoglycemic agents) | theoretical | Rosemary extract has demonstrated mild hypoglycemic effects in animal studies (improved insulin sensitivity, increased hepatic glucose utilization). Additive blood glucose lowering is theoretically possible. |
| CYP450 substrates (theoretical) (Various) | theoretical | In vitro studies suggest that rosemary extract and some of its constituents (carnosic acid, carnosol) may modulate certain cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP3A4). The direction and magnitude of effect vary by constituent and study. At dietary and therapeutic doses, clinically significant CYP450-mediated interactions are not well documented. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
AHPA Botanical Safety Handbook class 2b: not to be used during pregnancy in therapeutic doses. The emmenagogue (menstruation-promoting) and potential uterotonic properties of rosemary at high doses are the basis for this classification. Camphor in the essential oil can stimulate uterine contractions. However, culinary use of rosemary as a food flavoring during pregnancy is universally considered safe -- the concern applies specifically to concentrated medicinal preparations (therapeutic doses of tinctures, standardized extracts, or essential oil). Lactation data is insufficient; rosemary enters breast milk in small amounts after dietary consumption, but no adverse effects have been reported from dietary or moderate medicinal use during breastfeeding. The Commission E contraindicates rosemary essential oil preparations during pregnancy. Conservative guidance: avoid therapeutic-dose rosemary supplements and essential oil during pregnancy; culinary use as a seasoning herb is safe.
Adverse Effects
References
Monograph Sources
- [1] Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Rosemary leaf (Rosmarini folium) — positive monograph. American Botanical Council, Austin, TX / Integrative Medicine Communications, Boston, MA (1998)
- [2] European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Rosmarinus officinalis L., folium. EMA/HMPC/13631/2009. Assessment report on Rosmarinus officinalis L., folium and aetheroleum. EMA/HMPC/13631/2009. European Medicines Agency, London (2010)
- [3] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003)
- [4] Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine, 2nd edition. Churchill Livingstone / Elsevier, Edinburgh (2013)
- [5] British Herbal Medicine Association. British Herbal Pharmacopoeia, 4th edition. Monograph: Rosmarinus officinalis. British Herbal Medicine Association, Exeter (1996)
- [6] Gardner Z, McGuffin M (eds). American Herbal Products Association's Botanical Safety Handbook, 2nd edition. CRC Press / American Herbal Products Association, Boca Raton, FL (2013)
Clinical Studies
- [7] Moss M, Oliver L. Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma. Ther Adv Psychopharmacol (2012) ; 2 : 103-113 . DOI: 10.1177/2045125312436573 . PMID: 23983963
- [8] Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR. Short-term study on the effects of rosemary on cognitive function in an elderly population. J Med Food (2012) ; 15 : 10-17 . DOI: 10.1089/jmf.2011.0005 . PMID: 21877951
- [9] Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. SKINmed (2015) ; 13 : 15-21 . PMID: 25842469
- [10] Perry NSL, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol (2000) ; 52 : 895-902 . DOI: 10.1211/0022357001774598 . PMID: 10933142
- [11] Satoh T, Kosaka K, Itoh K, Kobayashi A, Yamamoto M, Shimojo Y, Kitajima C, Cui J, Kamins J, Okamoto S, Izumi M, Shirasawa T, Lipton SA. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem (2008) ; 104 : 1116-1131 . DOI: 10.1111/j.1471-4159.2007.05039.x . PMID: 17995931
- [12] Johnson JJ. Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett (2011) ; 305 : 1-7 . DOI: 10.1016/j.canlet.2011.02.005 . PMID: 21382660
Traditional Texts
- [13] Gerard J. The Herball or General Historie of Plantes. London: John Norton (1597)
- [14] Culpeper N. The English Physician (Culpeper's Herbal). London (1652)
Pharmacopeias & Reviews
- [15] Council of Europe. European Pharmacopoeia, 11th edition. Monographs: Rosmarini folium (Rosemary leaf); Rosmarini aetheroleum (Rosemary oil). European Directorate for the Quality of Medicines & Healthcare (EDQM), Strasbourg (2023)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.